1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters

Showing 1,267 results.

Thumbnail for Contemporary Corticosteroid Prescribing Patterns and Practice Variation in Patients with Lymphoma: A Real-World, Multisite Observational Study

ABCL - 1094

Contemporary Corticosteroid Prescribing Patterns and Practice Variation in Patients with Lymphoma: A Real-World, Multisite Observational Study

Emma St Martin

Poster Presenter: Emma St Martin

ABCL - 1115

HIV-Associated Burkitt Lymphoma in the Modern Era: The Prognostic Impact of CD4 Counts Below 200 Cells/µL

Ver?nica Steffania Corral Herrera

Poster Presenter: Ver?nica Steffania Corral Herrera

ABCL - 1163

Reproductive Outcomes After Chemotherapy in Young Women With Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis

Shreya Patel

Poster Presenter: Shreya Patel

ABCL - 1181

Time to Treatment and Care Pathways in Newly Diagnosed DLBCL: A Real-World Eastern European Study

Herdea Mihaela-Sabrina

Poster Presenter: Herdea Mihaela-Sabrina

$Thumbnail for Safety and Efficacy of Odronextamab in Relapsed/Refractory B-Cell Lymphomas: A Living Systematic Review with Subtypes and Post-CAR-T Analysis$

ABCL - 1267

Safety and Efficacy of Odronextamab in Relapsed/Refractory B-Cell Lymphomas: A Living Systematic Review with Subtypes and Post-CAR-T Analysis

Abrahim Danish Durrani

Poster Presenter: Abrahim Danish Durrani

Thumbnail for Reversal of Declining Gastrointestinal Hemorrhage-Associated Mortality in Hematologic Malignancies in the United States: A CDC WONDER Analysis

ABCL - 1276

Reversal of Declining Gastrointestinal Hemorrhage-Associated Mortality in Hematologic Malignancies in the United States: A CDC WONDER Analysis

Gaurav Sharma

Poster Presenter: Gaurav Sharma

ABCL - 1303

Mortality Trends Across Non-Hodgkin Lymphoma Subtypes in Older Adults: A 25-Year CDC WONDER Analysis (1999-2024)

Aamer Ahmad

Poster Presenter: Aamer Ahmad

$Thumbnail for Prior Bendamustine Exposure Within 12 Months and Outcomes After CAR-T or Bispecific Antibody Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Real-World Analysis$

ABCL - 1313

Prior Bendamustine Exposure Within 12 Months and Outcomes After CAR-T or Bispecific Antibody Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Real-World Analysis

Archit Srivastava

Poster Presenter: Archit Srivastava

Thumbnail for Efficacy and Safety of Programmed Cell Death-1 Inhibitors in Relapsed Immune-Privileged Site Lymphomas: A Systematic Review and Meta-Analysis

ABCL - 1318

Efficacy and Safety of Programmed Cell Death-1 Inhibitors in Relapsed Immune-Privileged Site Lymphomas: A Systematic Review and Meta-Analysis

Bashar M Al Zoubi

Poster Presenter: Bashar M Al Zoubi